BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 117559
Published online Aug 27, 2026. doi: 10.4240/wjgs.117559
Table 4 Univariate analysis of factors affecting disease-free survival
Factor
HR
95%CI
P value
Gender (male vs female)1.1530.682-1.9500.596
Age (> 60 years vs ≤ 60 years)1.2840.768-2.1460.339
ECOG score (2 vs 0-1)1.5620.785-3.1070.204
Tumor location (colon vs rectum)0.8940.524-1.5240.681
Differentiation (poor vs moderate-well)1.4180.757-2.6560.275
pT stage (T4 vs T3)a1.8561.126-3.0590.015a
pN stage (N2 vs N0-1)a1.9241.187-3.1180.008a
Lymph node metastasis (N+ vs N0)a1.8321.145-2.9300.012a
Vascular invasion (yes vs no)1.4730.886-2.4490.136
Neural invasion (yes vs no)a1.7261.041-2.8630.034a
Margin status (positive vs negative)a2.1681.243-3.7810.006a
Preoperative CEA (elevated vs normal)a1.6281.021-2.5960.041a
Preoperative CA19-9 (elevated vs normal)1.3840.824-2.3230.218
Surgical approach (laparoscopic vs open)0.8230.495-1.3680.452
Neoadjuvant therapy (yes vs no)0.7650.413-1.4180.398
Chemotherapy regimen (single vs combination)1.2450.735-2.1090.415
Target delineation (inaccurate vs accurate)a2.2541.356-3.7460.002a


Write to the Help Desk